Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Should clinical trials with concurrent economic analyses be blinded?

Article Abstract:

It is probably best to determine the cost effectiveness of a medical treatment by doing an unblinded randomized clinical trial that is based on actual clinical practice. Blinding in a clinical trial means that the physician and patients do not know who is getting the treatment and who is getting a placebo. This is necessary because prior knowledge can bias the conclusion of the study. All trials to determine the clinical effectiveness of a treatment should be blinded. However, the trial to determine the treatment's economic impact should be unblinded. These trials should only be done if the treatment has been shown to be effective.

Author: Freemantle, Nick, Drummond, Michael
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
Methods, Clinical trials, Cost benefit analysis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Impact of Formal Continuing Medical Education: Do Conferences, Workshops, Rounds, and Other Traditional Continuing Education Activities Change Physician Behavior or Health Care Outcomes?

Article Abstract:

Continuing medical education (CME) programs may not always lead to changes in doctors' behavior. Most CME programs are delivered in the form of a lecture, conference, or meeting. A review of 14 studies of CME revealed nine positive changes in clinical practice as a result of attending a CME program. However, few of these changes resulted in a change in health care outcomes. The most effective CME programs are those that require active participation rather than listening passively to a lecture.

Author: Davis, Dave, Freemantle, Nick, O'Brien, Mary Ann Thomson, Wolf, Fredric M., Mazmanian, Paul, Taylor-Vaisey, Anne
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
Evaluation, Physicians, Behavior, Medical professions, Continuing medical education

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


When Is It Cost-effective to Change the Behavior of Health Professionals? (Special Communication)

Article Abstract:

A technique is presented for calculating the cost-effectiveness of a policy change, using as an example an educational program that tried to change the prescribing habits of British doctors. Implementing a policy change costs money over and above the cost of the actual treatment. The cost of the implementation may exceed the money saved by using the new treatment.

Author: Mason, James, Freemantle, Nick, Nazareth, Irwin, Eccles, Martin, Haines, Andrew, Drummond, Michael
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Drugs, Economic aspects, Prescriptions (Drugs), Medical policy, Health policy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Similar abstracts:
  • Abstracts: Clinical economics: a guide to the economic analysis of clinical practices. Transforming Insurance Coverage Into Quality Health Care: Voltage Drops From Potential to Delivered Quality
  • Abstracts: Omphalocele: clinical outcomes in cases with normal karyotypes. Renal biopsy and pregnancy
  • Abstracts: Medical treatment of peptic ulcer disease: practice guidelines. Process of Care and Outcomes for Elderly Patients Hospitalized With Peptic Ulcer Disease Results From a Quality Improvement Project
  • Abstracts: Are clinical trials a cost-effective investment? Academic mentoring: How to give it and how to get it. Effect of Restricting Contact Between Pharmaceutical Company Representatives and Internal Medicine Residents on Posttraining Attitudes and Behavior
  • Abstracts: Sudden infant death syndrome: resurgent research offers hope. Clinical Presentation of Inhalational Anthrax Following Bioterrorism Exposure: Report of 2 Surviving Patients. (Original Contribution)
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.